These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36567775)

  • 1. Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma.
    Shen N; Yu Y; Zhang R; Guo Y; Liu M; Tan M; Liu J; Bai J; Li L; Liu K; Wang R; He J
    Int J Clin Pract; 2022; 2022():2637581. PubMed ID: 36567775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of CD30 in Patients with Diffuse Large B-Cell Lymphoma and Clinical Significance].
    Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
    Huang H; Fan L; Fu D; Lin Q; Shen J
    Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical characteristics of 681 patients with diffuse large B-cell lymphoma].
    Wen JJ; Liu ZB; Xu J; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1004-9. PubMed ID: 23363791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes.
    Bao C; Gu J; Huang X; You L; Zhou Z; Jin J
    Cytokine; 2023 Sep; 169():156289. PubMed ID: 37453327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients.
    Wu XB; Hou SL; Liu H
    World J Clin Cases; 2021 Nov; 9(32):9825-9834. PubMed ID: 34877321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and Clinical Significance of Exosome Component 4 in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma].
    Hong JQ; Huang QH; Huang ZY; Fan LP; Lin QY; Huang HB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1684-1689. PubMed ID: 38071046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era.
    Sang W; Zhou H; Qin Y; Shen Z; Yan D; Sun C; Song X; Ma Y; Tu D; Bian Z; Nie S; Jin Y; Xu L; Li Z; Xu K
    Int J Hematol; 2021 Aug; 114(2):189-198. PubMed ID: 33893987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma.
    Yue W; Liu B; Gao L; He M; Wang J; Zhang W; Chen L; Hu X; Xu L; Yang J
    Clin Chim Acta; 2018 Oct; 485():316-322. PubMed ID: 30006285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and Clinical Prognostical Significance of RIP2 in Diffuse Large B Cell Lymphoma].
    Wang XC; Ding KY; Wang XQ; Wang ZH; Wang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):166-170. PubMed ID: 29397837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma.
    Akkas BE; Vural GU
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):148-52. PubMed ID: 24094371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of CD30 in Diffuse Large B Cell Lymphoma and Its Clinical Significance].
    Zhao YF; Qian SX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):717-21. PubMed ID: 27342497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum apolipoprotein A1 level predicts poor prognosis of patients with diffuse large B-cell lymphoma in the real world: a retrospective study.
    Huang X; Wang Y; Huang Z; Chen X; Lin Q; Huang H; Fan L
    BMC Cancer; 2024 Jan; 24(1):62. PubMed ID: 38212711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expressions of VEGF and CXCR4 in diffuse large B cell lymphoma and their clinical significances].
    Guo Q; Wang JJ; Li F; Yang HL; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):383-6. PubMed ID: 23628037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and Prognostic Value of Cytokines in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma].
    Man Y; Ge CQ; Li ZZ; Yang TH; Wang YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1050-1055. PubMed ID: 37551476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Clinical Significance].
    Wang M; Zhang PP; Zhu Q; Hu ZL; Bai X; Wu YP; Li JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):112-119. PubMed ID: 38387908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.